PPT Slide

Oral Heparin

With reproducible clinical endpoints:

• Fixed dose
• No monitoring
• Superior dosing regimen
  An already superior product:
• Well established safety and efficacy profile
  An added benefit:
• ORAL

Competitive Advantage

Previous slide

Next slide

Back to first slide

View graphic version